Xenon Pharmaceuticals Inc (XENE)
39.80
+0.46
(+1.17%)
USD |
NASDAQ |
Nov 21, 16:00
38.11
-1.69
(-4.25%)
Pre-Market: 08:10
Xenon Pharmaceuticals Price to Book Value: 3.803 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.803 |
| November 20, 2024 | 3.759 |
| November 19, 2024 | 3.713 |
| November 18, 2024 | 3.661 |
| November 15, 2024 | 3.806 |
| November 14, 2024 | 3.990 |
| November 13, 2024 | 4.011 |
| November 12, 2024 | 4.146 |
| November 11, 2024 | 4.211 |
| November 08, 2024 | 4.300 |
| November 07, 2024 | 4.371 |
| November 06, 2024 | 4.294 |
| November 05, 2024 | 4.116 |
| November 04, 2024 | 3.963 |
| November 01, 2024 | 3.961 |
| October 31, 2024 | 3.906 |
| October 30, 2024 | 3.980 |
| October 29, 2024 | 3.969 |
| October 28, 2024 | 3.965 |
| October 25, 2024 | 3.964 |
| October 24, 2024 | 3.976 |
| October 23, 2024 | 3.958 |
| October 22, 2024 | 4.060 |
| October 21, 2024 | 4.200 |
| October 18, 2024 | 4.262 |
| Date | Value |
|---|---|
| October 17, 2024 | 4.115 |
| October 16, 2024 | 4.049 |
| October 15, 2024 | 3.868 |
| October 14, 2024 | 3.967 |
| October 11, 2024 | 3.915 |
| October 10, 2024 | 3.839 |
| October 09, 2024 | 3.745 |
| October 08, 2024 | 3.897 |
| October 07, 2024 | 3.856 |
| October 04, 2024 | 3.870 |
| October 03, 2024 | 3.772 |
| October 02, 2024 | 3.880 |
| October 01, 2024 | 3.836 |
| September 30, 2024 | 3.740 |
| September 27, 2024 | 3.469 |
| September 26, 2024 | 3.447 |
| September 25, 2024 | 3.416 |
| September 24, 2024 | 3.494 |
| September 23, 2024 | 3.559 |
| September 20, 2024 | 3.604 |
| September 19, 2024 | 3.661 |
| September 18, 2024 | 3.599 |
| September 17, 2024 | 3.599 |
| September 16, 2024 | 3.589 |
| September 13, 2024 | 3.666 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.905
Minimum
Oct 28 2020
7.544
Maximum
Nov 05 2021
3.484
Average
3.231
Median
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals Inc | 3.236 |
| Edesa Biotech Inc | 2.390 |
| Lexaria Bioscience Corp | 3.374 |
| ESSA Pharma Inc | 0.606 |
| ImmunoPrecise Antibodies Ltd | 0.41 |
Price to Book Value Related Metrics
| PS Ratio | 229.02 |
| PEG Ratio | -1.040 |
| Price | 39.80 |
| Earnings Yield | -7.09% |
| Market Cap | 3.034B |
| PEGY Ratio | -1.040 |